BSX

Boston Scientific Corporation

Healthcare
44.39 +0.25 +0.57% Pre-Market
2026-10-16 • USD

Key Metrics

Market Cap 64.33B
EV 76.42B
Shares Out 1.45B
Revenue (ttm) 21.00B
Net Income 3.67B
Beta —
P/E —
Forward P/E —
EPS (ttm) $2.47
P/S 3.11
P/B 2.62
P/FCF 18.00
P/C 14.41
EV/Sales 3.64
EV/EBITDA 14.06
ROA 8.36%
ROE 15.21%
ROIC 10.5%
Gross Margin 69.93%
Oper. Margin 19.78%
Profit Margin 17.5%
Debt/Eq 0.51
LT Debt/Cap 30.45%
Quick Ratio 0.56
Current Ratio 1.24
Book/sh 16.96
Cash/sh 0.37
Div Yield —
Div TTM —
Payout Ratio —
SMA20 2.17%
SMA50 -3.68%
SMA200 -24.89%
Volume 12,408,372
Avg Volume 19.70M
Rel Volume 0.63
Perf Week 1.25%
Perf Month 2.42%
Perf Quarter 0.82%
Perf Half Y -30.89%
Perf YTD -53.45%
Perf Year -55.27%
Perf 3Y -12.19%
Perf 5Y 0.59%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. The company…

Name
Boston Scientific Corporation
Sector
Healthcare
Industry
Medical Devices
CEO
Michael F. Mahoney · Chairman of the Board of Directors, President and Chief Executive Officer
Employees
59,000 as of 2025-12-31
IPO Date
2020-06-18
Phone
(508) 683-4000
Address
300 Boston Scientific Way, Marlborough, MA 01752-1234
Website
www.bostonscientific.com

Key Executives

Name Title FY Pay
Michael F. Mahoney Chairman of the Board of Directors, President and Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.